SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus: into single digits
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bill Wexler who wrote (20)1/15/1998 9:54:00 PM
From: BDR  Read Replies (2) of 1016
 
From the VVUS Q4 report:

<<Product revenues for the fourth quarter were $29.0 million, a decrease of $10.1 million or
26 percent from the third quarter. >>

Well, of course revenues are down 26%. The company announced that production was going to be reduced 25%, they are selling all they can make so revenue must go down about the same amount. But wait a minute. They announced the drop in production in early December, if memory serves, yet revenues for the ENTIRE quarter are down 26%. Either:

1)They knew at the start of the quarter (share price 32) that production was going to be reduced and didn't announce it until December after it had already lost 50% of its value

or

2)Sales were down for the whole quarter and the announcement at the end of the quarter was a smoke screen.

If demand is so great and they are selling all they can make, why the marketing campaign? Hmmmmmm...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News